Final Written Decision: original | Oct 31, 2023 | PAPER | BOARD |
Other: Hearing transcript | Sep 18, 2023 | PAPER | BOARD |
Petitioner's Updated Exhibit List | Aug 25, 2023 | PAPER | PETITIONER |
Petitioner's Demonstratives | Aug 25, 2023 | EXHIBIT | PETITIONER |
Patent Owner's Updated Exhibit List | Aug 25, 2023 | PAPER | PATENT OWNER |
Patent Owner Oral Hearing Demonstratives | Aug 25, 2023 | EXHIBIT | PATENT OWNER |
Patent Owner's Reply in Support of Motion to Exclude | Aug 17, 2023 | PAPER | PATENT OWNER |
Petitioner's Opposition to Patent Owner's Motion to Exclude | Aug 10, 2023 | PAPER | PETITIONER |
Petitioner's Updated Exhibit List | Aug 10, 2023 | PAPER | PETITIONER |
“Standard Affidavit,” from the Internet Archive Website, available at <https://archive.org/legal/affidavit.php> (last visited August 10, 2023) | Aug 10, 2023 | EXHIBIT | PETITIONER |
“Information Requests: The Internet Archive’s Policy for Responding to Information Requests,” from the Internet Archive Website, available at <https://archive.org/legal> (last visited August 10, 2023) | Aug 10, 2023 | EXHIBIT | PETITIONER |
Patent Owner's Objections to Petitioner's Evidence in Sur-Reply | Aug 9, 2023 | PAPER | PATENT OWNER |
Patent Owner's Motion to Exclude Evidence | Aug 3, 2023 | PAPER | PATENT OWNER |
Ex. 2109 - Fasano Transcript Excerpt | Aug 3, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2110 - Internet Archive Declarant Email Discussion | Aug 3, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2111 - Third Johnson Declaration | Aug 3, 2023 | EXHIBIT | PATENT OWNER |
Patent Owner's Updated Exhibit List | Aug 3, 2023 | PAPER | PATENT OWNER |
Petitioner's Sur-Reply to PO's Reply to Oppsn to Motion to Amend | Aug 3, 2023 | PAPER | PETITIONER |
Petitioner's Updated Exhibit List | Aug 3, 2023 | PAPER | PETITIONER |
Urso, et al., Improving the Delivery of Levodopa etc., 34 CNS Drugs 1149-63 (2020) | Aug 3, 2023 | EXHIBIT | PETITIONER |
Opening Expert Report of Peter Jenner Ph.D., Impax Laboratories v. Actavis Laboratories, 2:15-06934 (DNJ May 18, 2017) | Aug 3, 2023 | EXHIBIT | PETITIONER |
US Patent No. 9,089,608 B2 to Hsu et al. | Aug 3, 2023 | EXHIBIT | PETITIONER |
U.S. Pat. Appl. Publ. No. US2014/00221489 A1 | Aug 3, 2023 | EXHIBIT | PETITIONER |
Deposition Transcript of Dr. Alfonso Fasano taken July 13, 2023 | Aug 3, 2023 | EXHIBIT | PETITIONER |
Deposition Transcript of Dr. Peter Jenner taken July 19, 2023 | Aug 3, 2023 | EXHIBIT | PETITIONER |
Deposition Transcript of Dr. Sara E. Rosenbaum taken July 25, 2023 | Aug 3, 2023 | EXHIBIT | PETITIONER |
Setting Oral Argument 37 C.F.R. § 42.70 | Jul 31, 2023 | PAPER | BOARD |
Order: Granting Patent Owner's Motion for Pro Hac Vice Admission of Susan M. Gerber - 37 CFR 42.10 | Jul 20, 2023 | PAPER | BOARD |
Order: Granting Petitioner's Motion for Pro Hac Vice Admission of Mark R. Weinstein - 37 CFR 42.10(c) | Jul 20, 2023 | PAPER | BOARD |
Patent Owner's Updated Power of Attorney | Jul 19, 2023 | PAPER | PATENT OWNER |
Patent Owner's Updated Mandatory Notices | Jul 14, 2023 | PAPER | PATENT OWNER |
Patent Owner's Request for Oral Argument | Jul 13, 2023 | PAPER | PATENT OWNER |
Petitioner's Request for Oral Hearing | Jul 13, 2023 | PAPER | PETITIONER |
Petitioner's Notice of Cross-Examination of Peter Jenner Ph.D. | Jul 12, 2023 | PAPER | PETITIONER |
Patent Owner's Opposition to Petitioner's Motion to Strike | Jul 12, 2023 | PAPER | PATENT OWNER |
Petitioner's Unopposed Motion for Pro Hac Vice Admission of Mark R. Weinstein | Jul 11, 2023 | PAPER | PETITIONER |
Petitioner's Updated Exhibit List | Jul 11, 2023 | PAPER | PETITIONER |
Biography of Mark R. Weinstein | Jul 11, 2023 | EXHIBIT | PETITIONER |
Declaration of Mark R. Weinstein ISO Petitioner's Motion for Pro Hac Vice Admission | Jul 11, 2023 | EXHIBIT | PETITIONER |
Petitioner's Notice of Cross-Examination of Alfonso Fasano MD PhD | Jul 11, 2023 | PAPER | PETITIONER |
Petitioner's Notice of Cross-Examination of Sara E. Rosenbaum Ph.D. | Jul 11, 2023 | PAPER | PETITIONER |
Motion for Pro Hac Vice Admission of Susan Gerber | Jul 10, 2023 | PAPER | PATENT OWNER |
Gerber Declaration ISO Motion for Pro Hac Vice | Jul 10, 2023 | EXHIBIT | PATENT OWNER |
Patent Owner's Updated Mandatory Notice | Jul 10, 2023 | PAPER | PATENT OWNER |
Patent Owner's Updated Exhibit List | Jul 10, 2023 | PAPER | PATENT OWNER |
Petitioner's Motion to Strike | Jul 3, 2023 | PAPER | PETITIONER |
Conditionally Granting Petitioner’s Unopposed Motion to Withdraw Counsel and Substitute New Counsel 37 C.F.R. § 42.10 | Jun 30, 2023 | PAPER | BOARD |
ORDER Conduct of the Proceeding Modifying Scheduling Order 37 C.F.R. sec 42.5 | Jun 30, 2023 | PAPER | BOARD |
Email From: Biegler, Geoff To: Trials Cc: Insogna, Anthony M.; Geers, Sarah A.; Yang, Kunyong; Kanouse, Laura M.; Jones, Evan C.; Johnson, Matthew W RE: PGR2022-00040 Date: June 28, 2023 | Jun 30, 2023 | EXHIBIT | BOARD |
Petitioner's Updated Power of Attorney | Jun 30, 2023 | PAPER | PETITIONER |
Petitioner's Updated Mandatory Notice Re Lead and Back Up Counsel | Jun 30, 2023 | PAPER | PETITIONER |
ORDER Conduct of the Proceeding Granting Petitioner Authorization to File Motion to Strike 37 C.F.R. 42.5 | Jun 27, 2023 | PAPER | BOARD |
Exhibit 3003 | Jun 27, 2023 | EXHIBIT | BOARD |
Petitioner's Unopposed Motion to Withdraw Counsel and Substitute New Counsel | Jun 15, 2023 | PAPER | PETITIONER |
Ex. 2066 - US 8,114,833 | Jun 12, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2067 - Forrest Transcript IPR2020-00324 | Jun 12, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2068 - Forrest Declaration IPR2016-01316 | Jun 12, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2069 - US 8,088,412 | Jun 12, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2070 - Forrest Transcript | Jun 12, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2071 - Aldred 2010 | Jun 12, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2072 - Remington 2000 | Jun 12, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2073 - Goole 2009 | Jun 12, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2074 - Leveque 2014 | Jun 12, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2075 - Broadhead 2009 | Jun 12, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2076 - Katzenschlager 2018 | Jun 12, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2077 - Ex. 1005 Figure 1 | Jun 12, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2078 - Ex. 1005 Figure 2 | Jun 12, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2079 - Ex. 1005 Figure 3 | Jun 12, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2080 - Ex. 1005 Figure 4 | Jun 12, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2081 - Kurth 1997 | Jun 12, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2082- US-20230157985 | Jun 12, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2083 - Rosenbaum 2011 | Jun 12, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2084 - Robertson 1989 | Jun 12, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2085 - Leppert 1988 | Jun 12, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2086 - Rosenbaum Declaration | Jun 12, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2087 - Fasano Declaration | Jun 12, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2088 - Jenner Declaration | Jun 12, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2089 - Merck Index | Jun 12, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2090 - WO2005023185 | Jun 12, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2091 - Marcolino-Junior 2001 | Jun 12, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2092 - Bredberg 1993 | Jun 12, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2093 - Nutt 1984 | Jun 12, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2095 - US20070027216 | Jun 12, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2097 - Bundgaard 1988 | Jun 12, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2100 - Fox 2014 - Chap 2 | Jun 12, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2101 - Fox 2014 - Chap 4 | Jun 12, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2102 - Schneider 1997 | Jun 12, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2103 - Forrest Declaration IPR2022-00657 | Jun 12, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2104 - Nema 2010 - Chap 6 | Jun 12, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2105 - Nema 2010 Ch. 5 | Jun 12, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2106 - Isaac 2012 | Jun 12, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2107 - Second Johnson Declaration | Jun 12, 2023 | EXHIBIT | PATENT OWNER |
Patent Owner Updated Exhibit List | Jun 12, 2023 | PAPER | PATENT OWNER |
Patent Owner's Reply in Support of Its Motion to Amend | Jun 12, 2023 | PAPER | PATENT OWNER |
PRELIMINARY GUIDANCE PATENT OWNER’S MOTION TO AMEND | May 26, 2023 | PAPER | BOARD |
Petitioner's Notice of Supplemental Authority | May 24, 2023 | PAPER | PETITIONER |
Forrest Deposition Notice | May 23, 2023 | PAPER | PATENT OWNER |
Patent Owner's Objections to Petitioner's Evidence in Response to Motion to Amend | May 8, 2023 | PAPER | PATENT OWNER |
Petitioner's Opposition to Patent Owner's Non-Contingent Motion to Amend | May 1, 2023 | PAPER | PETITIONER |
Declaration of Laird Forrest, Ph.D | May 1, 2023 | EXHIBIT | PETITIONER |
Email from Peter LeWitt to Oron Yacoby-Zeevi re MDS Abstract Disposition Notification dated March 13, 2012 | May 1, 2023 | EXHIBIT | PETITIONER |
Yacoby-Zeevi, et al., Maintenance of Constant Steady State Therapeutic Plasma Concentrations of Levodopa following its Continuous Subcutaneous Administration with Carbidopa | May 1, 2023 | EXHIBIT | PETITIONER |
Email from Dana Hila to Sheila Oren dated June 12, 2012 | May 1, 2023 | EXHIBIT | PETITIONER |
Huters, et al. Scalable Asymmetric Syntheses of Foslevodopa and Foscarbidopa Drug Substances for the Treatment of Parkinson's Disease | May 1, 2023 | EXHIBIT | PETITIONER |
Voight, et al. Fueling the Pipeline via Innovations in Organic Synthesis | May 1, 2023 | EXHIBIT | PETITIONER |
Rosebraught et al. Foslevodopa/Foscarbidopa: A New Subcutaneous Treatment for Parkinson's Disease | May 1, 2023 | EXHIBIT | PETITIONER |
Connolly, et al. Pharmacological Treatment of Parkinson Disease A Review | May 1, 2023 | EXHIBIT | PETITIONER |
Joshua, et al. The dynamics of dopamine in control of motor behavior | May 1, 2023 | EXHIBIT | PETITIONER |
Alison Abbott, Levodopa the story so far, Outlook Parkinson's Disease | May 1, 2023 | EXHIBIT | PETITIONER |
Nutt, et al. The Effect of Carbidopa on the Pharmacokmetics of Intravenously Ahnistered Levodopa The Mechanism of Action in the Treatment of Parlunsonism | May 1, 2023 | EXHIBIT | PETITIONER |
American Academy of Neurology, Management of Parkinson's disease | May 1, 2023 | EXHIBIT | PETITIONER |
Frankel, et al., The effects of oral protein on the absorption of intraduodenal levodopa and motor performance | May 1, 2023 | EXHIBIT | PETITIONER |
Dickman, The Syringe Driver Continuous subcutaneous infusions in palliative care | May 1, 2023 | EXHIBIT | PETITIONER |
Heimann, et al., StalevoTM carbidopa, levoclopa and entacapone Tablets | May 1, 2023 | EXHIBIT | PETITIONER |
Pappert, et al., Levodopa Stability in Solution Time Course, Environmental Effects, and Practical Recommendations for Clinical Use | May 1, 2023 | EXHIBIT | PETITIONER |
Avis, et al., Parenteral Preparations, Remington The Science and Practice of Pharmacy | May 1, 2023 | EXHIBIT | PETITIONER |
York, The design of dosage forms, Pharmaceutics The Science of Dosage Form Design | May 1, 2023 | EXHIBIT | PETITIONER |
Hancock, et al., The use of solubility parameters in pharmaceutical dosage form design | May 1, 2023 | EXHIBIT | PETITIONER |
Nema, et al., Excipients and Their Use in Injectable Products | May 1, 2023 | EXHIBIT | PETITIONER |
Bontempo, Formulation Development, Development of Biopharmaceutical Parenteral Dosage Forms | May 1, 2023 | EXHIBIT | PETITIONER |
EMD for Pharmaceutical Production, EMD Chemicals Inc | May 1, 2023 | EXHIBIT | PETITIONER |
Stella, et al., Prodrugs Challenges and Rewards | May 1, 2023 | EXHIBIT | PETITIONER |
Hull, Guideline limit volumes for dosing animals in the preclinical stage of safety evaluation | May 1, 2023 | EXHIBIT | PETITIONER |
Frazão, et al., Four-level levodopa adsorption on C60 fullerene for transdermal and oral administration a computational study | May 1, 2023 | EXHIBIT | PETITIONER |
Diehl, et al., A Good Practice Guide to the Administration of Substances and Removal of Blood, Including Routes and Volumes | May 1, 2023 | EXHIBIT | PETITIONER |
Excerpts from Rowe, et al. Handbook of Pharmaceutical Excipients | May 1, 2023 | EXHIBIT | PETITIONER |
Strickley, Parenteral Formulations of Small Molecules Therapeutics Marketed in the United States | May 1, 2023 | EXHIBIT | PETITIONER |
Translation Certificate for Exhibits 1082 and 1083 | May 1, 2023 | EXHIBIT | PETITIONER |
Translation of pages 1-4 of VYALEV Post-Marketing Review (Document A from Exhibit 1081) | May 1, 2023 | EXHIBIT | PETITIONER |
Translation of pages 1-10 of VYALEV Deliberation Report (Document B from Exhibit 1081) | May 1, 2023 | EXHIBIT | PETITIONER |
Denying Petitioner Motion to Compel Routine Discovery, or in the Alternative, Additional Discovery 37 C.F.R. §§ 42.51, 42.224 | Apr 10, 2023 | PAPER | BOARD |
Order: Granting Petitioners Unopposed Motion to File Under Seal | Mar 30, 2023 | PAPER | BOARD |
Patent Owner's Opposition to Petitioner's Motion for Additional Discovery | Mar 30, 2023 | PAPER | PATENT OWNER |
Petitioner's Motion to Seal | Mar 28, 2023 | PAPER | PETITIONER |
Petitioner's Motion to Compel Routine Discovery, or in the Alternative, Additional Discovery | Mar 20, 2023 | PAPER | PETITIONER |
Granting Petitioner Authorization to File Motion for Discovery 37 C.F.R. § 42.5; 37 C.F.R. § 42.20(b) | Mar 14, 2023 | PAPER | BOARD |
Denying Patent Owner Motion to Seal 37 C.F.R. §§ 42.14, 42.54 | Mar 14, 2023 | PAPER | BOARD |
Exhibit 3002 | Mar 14, 2023 | EXHIBIT | BOARD |
Motion to Seal Exhibit 2062 | Feb 6, 2023 | PAPER | PATENT OWNER |
Patent Owner's Motion to Amend | Feb 6, 2023 | PAPER | PATENT OWNER |
Patent Owner's Updated Exhibit List | Feb 6, 2023 | PAPER | PATENT OWNER |
Ex. 2040 - NeuroDerm.com-Pipeline | Feb 6, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2041 - NeuroDerm.com-Pipeline-ND0612 | Feb 6, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2042 - US 3,891,696 | Feb 6, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2043 - US 3,939,253 | Feb 6, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2044 - US 3,998,799 | Feb 6, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2045 - US 4,035,507 | Feb 6, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2046 - US 4,065,566 | Feb 6, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2047 - US 4,163,058 | Feb 6, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2048 - US 10,258,585 | Feb 6, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2049 - US 11,331,293 | Feb 6, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2050 - Sloan-Takeda | Feb 6, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2051 - Chesler Opinion | Feb 6, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2052 - Ex 1005 Left-Bottom | Feb 6, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2053 - Ex 1005 - Top-Middle | Feb 6, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2054 - Ex 1005 - Top-Right | Feb 6, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2055 - Ex 1005 - Bottom-Middle | Feb 6, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2056 - Ex 1005 - Bottom-Right | Feb 6, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2057 - International Congress | Feb 6, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2058 - Mitsubishi Tanabe Article | Feb 6, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2059 - D. NJ Order | Feb 6, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2060 - 418 Application File History | Feb 6, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2061 - Sloan Transcript | Feb 6, 2023 | EXHIBIT | PATENT OWNER |
CONFIDENTIAL - Ex. 2062 - LeWitt Transcript Unredacted | Feb 6, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2063 - LeWitt Transcript Redacted | Feb 6, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2064 - Munford Transcript | Feb 6, 2023 | EXHIBIT | PATENT OWNER |
Ex. 2065 - 2012 MDS Conference Abstracts | Feb 6, 2023 | EXHIBIT | PATENT OWNER |
Patent Owner's Objections to Supplemental Information Evidence | Jan 23, 2023 | PAPER | PATENT OWNER |
Petitioner's Updated Exhibit List | Jan 17, 2023 | PAPER | PETITIONER |
Printout of the Home Page of Petitioner's website from the Wayback Machine as of August 2, 2013 | Jan 17, 2023 | EXHIBIT | PETITIONER |
Printout of the News Page of Petitioner's website from the Wayback Machine as of August 2, 2013 | Jan 17, 2023 | EXHIBIT | PETITIONER |
2013 site map of Petitioner's website from the Wayback Machine relating to the Petitioner's Home Page | Jan 17, 2023 | EXHIBIT | PETITIONER |
2013 site map of Petitioner's website from the Wayback Machine relating to the Petitioner's News Page | Jan 17, 2023 | EXHIBIT | PETITIONER |
Declaration of Nathaniel E. Frank-White | Jan 17, 2023 | EXHIBIT | PETITIONER |
Declaration of June Anne Munford | Jan 17, 2023 | EXHIBIT | PETITIONER |
Letter from The Movement Disorder Society to Peter LeWitt of March, 2012 | Jan 17, 2023 | EXHIBIT | PETITIONER |
Updated LeWitt Deposition Notice | Jan 13, 2023 | PAPER | PATENT OWNER |
Order: Granting Petitioner's Motion to Submit Supplemental Information - 37 CFR 42.223(a) | Jan 13, 2023 | PAPER | BOARD |
Petitioner's Updated Mandatory Notices | Jan 12, 2023 | PAPER | PETITIONER |
LeWitt Deposition Notice | Jan 10, 2023 | PAPER | PATENT OWNER |
Sloan Deposition Notice | Jan 10, 2023 | PAPER | PATENT OWNER |
Munford Deposition Notice | Jan 10, 2023 | PAPER | PATENT OWNER |
ORDER Granting Petitioners Motions for Pro Hac Vice Admission of Jonathan E. Singer and Geoffrey D. Biegler 37 C.F.R. sec 42.10 c | Jan 5, 2023 | PAPER | BOARD |
Patent Owner's Opposition to Motion to File Supplemental Information | Dec 27, 2022 | PAPER | PATENT OWNER |
Motion for Pro Hac Vice Admission of Geoffrey D. Biegler | Dec 27, 2022 | PAPER | PETITIONER |
Declaration of Geoffrey D. Biegler | Dec 27, 2022 | EXHIBIT | PETITIONER |
Motion for Pro Hac Vice Admission of Jonathan E. Singer | Dec 27, 2022 | PAPER | PETITIONER |
Declaration of Jonathan E. Singer | Dec 27, 2022 | EXHIBIT | PETITIONER |
Patent Owner's Updated Mandatory Notices | Dec 20, 2022 | PAPER | PATENT OWNER |
Petitioner's Motion to Submit Supplemental Information and Appendices | Dec 19, 2022 | PAPER | PETITIONER |
Patent Owner's Objections to Evidence | Nov 29, 2022 | PAPER | PATENT OWNER |
Institution Decision: Grant | Nov 14, 2022 | PAPER | BOARD |
Scheduling Order | Nov 14, 2022 | PAPER | BOARD |
Ex. 3001 | Nov 14, 2022 | EXHIBIT | BOARD |
Patent Owner's Preliminary Sur-Reply | Sep 14, 2022 | PAPER | PATENT OWNER |
Petitioner's Reply to Patent Owner's Preliminary Response | Sep 2, 2022 | PAPER | PETITIONER |
Ex. 2001 - U.S. 9,446,059 | Aug 17, 2022 | EXHIBIT | PATENT OWNER |
Ex. 2002 - U.S. 15/216,009 | Aug 17, 2022 | EXHIBIT | PATENT OWNER |
Ex. 2003 - U.S. 10,174,061 | Aug 17, 2022 | EXHIBIT | PATENT OWNER |
Ex. 2004 - U.S. 10,730,895 | Aug 17, 2022 | EXHIBIT | PATENT OWNER |
Ex. 2006 - Caraco 2013 | Aug 17, 2022 | EXHIBIT | PATENT OWNER |
Ex. 2007 - U.S. 14/919,418 File History | Aug 17, 2022 | EXHIBIT | PATENT OWNER |
Ex. 2008 - U.S. 15/216,009 File History | Aug 17, 2022 | EXHIBIT | PATENT OWNER |
Ex. 2010 - U.S. 16/210,996 File History | Aug 17, 2022 | EXHIBIT | PATENT OWNER |
Ex. 2011 - U.S. 8,747,854 | Aug 17, 2022 | EXHIBIT | PATENT OWNER |
Ex. 2012 - U.S. 8,557,239 | Aug 17, 2022 | EXHIBIT | PATENT OWNER |
Ex. 2018 - Adar 2017 | Aug 17, 2022 | EXHIBIT | PATENT OWNER |
Ex. 2019 - Ramot 2017 | Aug 17, 2022 | EXHIBIT | PATENT OWNER |
Ex. 2020 - Adar S4.003 2017 | Aug 17, 2022 | EXHIBIT | PATENT OWNER |
Ex. 2021 - U.S. 11,213,502 | Aug 17, 2022 | EXHIBIT | PATENT OWNER |
Ex. 2022 - NeuroDerm SEC Form F-1A | Aug 17, 2022 | EXHIBIT | PATENT OWNER |
Ex. 2023 - Poewe 2021 | Aug 17, 2022 | EXHIBIT | PATENT OWNER |
Ex. 2024 - LeWitt 2012 | Aug 17, 2022 | EXHIBIT | PATENT OWNER |
Ex. 2025 - LeWitt 2013 | Aug 17, 2022 | EXHIBIT | PATENT OWNER |
Ex. 2026 - Silbergleit 2015 | Aug 17, 2022 | EXHIBIT | PATENT OWNER |
Ex. 2027 - Loeffler 2016 | Aug 17, 2022 | EXHIBIT | PATENT OWNER |
Ex. 2028 - Ondo 2017 | Aug 17, 2022 | EXHIBIT | PATENT OWNER |
Ex. 2029 - LeWitt 2018 | Aug 17, 2022 | EXHIBIT | PATENT OWNER |
Ex. 2030 - LeWitt 2020 | Aug 17, 2022 | EXHIBIT | PATENT OWNER |
Ex. 2031 - Isaacson 2020 | Aug 17, 2022 | EXHIBIT | PATENT OWNER |
Ex. 2032 - Hauser 2021 | Aug 17, 2022 | EXHIBIT | PATENT OWNER |
Ex. 2033 - MDS Program | Aug 17, 2022 | EXHIBIT | PATENT OWNER |
Ex. 2034 - CloudFlare | Aug 17, 2022 | EXHIBIT | PATENT OWNER |
Ex. 2035 - Archive-it Support | Aug 17, 2022 | EXHIBIT | PATENT OWNER |
Ex. 2036 - Web Crawler Access History for Ex. 1005 | Aug 17, 2022 | EXHIBIT | PATENT OWNER |
Ex. 2037 - Web Crawl Access Record for NeuroDerm.com | Aug 17, 2022 | EXHIBIT | PATENT OWNER |
Ex. 2038 - M. Johnson Declaration | Aug 17, 2022 | EXHIBIT | PATENT OWNER |
Patent Owner's Preliminary Response | Aug 17, 2022 | PAPER | PATENT OWNER |
Patent Owner's POA | Jun 2, 2022 | PAPER | PATENT OWNER |
Patent Owner's Mandatory Notices | Jun 2, 2022 | PAPER | PATENT OWNER |
NOTICE OF FILING DATE ACCORDED TO PETITION AND TIME FOR FILING PATENT OWNER PRELIMINARY RESPONSE | May 17, 2022 | PAPER | BOARD |
Petitioner's Power of Attorney | May 12, 2022 | PAPER | PETITIONER |
U.S. Patent No. 11,091,507 to Brian P. Enright et al | May 12, 2022 | EXHIBIT | PETITIONER |
Excerpts of File History of the 507 Patent Part 1 of 2 | May 12, 2022 | EXHIBIT | PETITIONER |
Excerpts of File History of the 507 Patent Part 2 of 2 | May 12, 2022 | EXHIBIT | PETITIONER |
Yacoby-Zeevi et al., Maintenance of Constant Steady State Therapeutic Plasma Concentrations of Levodopa Following Its Continuous Subcutaneous Administration With Carbidopa | May 12, 2022 | EXHIBIT | PETITIONER |
Nyholm et al., Pharmacokinetics of Levodopa, Carbidopa, and 3-O-Methyldopa Following 16-hour Jejunal Infusion of Levodopa-Carbidopa Intestinal Gel in Advanced Parkinsons Disease Patients | May 12, 2022 | EXHIBIT | PETITIONER |
Declaration of Nathaniel E. Frank-White | May 12, 2022 | EXHIBIT | PETITIONER |
International Parkinson and Movement Disorder Society | May 12, 2022 | EXHIBIT | PETITIONER |
LeWitt, Levodopa Therapy for Parkinsons Disease Pharmacokinetics and Pharmacodynamics | May 12, 2022 | EXHIBIT | PETITIONER |
LeWitt, The Pharmacology of Levodopa in Treatment of Parkinsons Disease An Update | May 12, 2022 | EXHIBIT | PETITIONER |
Contin et al., Pharmacokinetics of levodopa | May 12, 2022 | EXHIBIT | PETITIONER |
Quinn et al., Control of on/off phenomenon by continuous intravenous infusion of levodopa | May 12, 2022 | EXHIBIT | PETITIONER |
Pfeiffer, Transdermal drug delivery in Parkinsons disease | May 12, 2022 | EXHIBIT | PETITIONER |
Lundqvist, Continuous levodopa for advanced Parkinsons disease | May 12, 2022 | EXHIBIT | PETITIONER |
ND0612 for Parkinsons Disease | May 12, 2022 | EXHIBIT | PETITIONER |
Press Release, PR Newswire, BeyoND Phase 2b Data Indicates ND0612 Has a Positive Long-Term Safety Profile for People with Parkinsons Disease | May 12, 2022 | EXHIBIT | PETITIONER |
Press Release, NeuroDerm, Phase 3 of ND0612 clinical trial Initiated in the United States for Parkinsons disease with motor fluctuations | May 12, 2022 | EXHIBIT | PETITIONER |
U.S. Patent No. 10,730,895 to Kym et al | May 12, 2022 | EXHIBIT | PETITIONER |
U.S. Patent No. 10,174,061 to Cardinal-David et al | May 12, 2022 | EXHIBIT | PETITIONER |
U.S. Patent No. 9,446,059 to Cardinal-David et al | May 12, 2022 | EXHIBIT | PETITIONER |
Caraco et al., Constant Therapeutic Levodopa Plasma Concentrations Maintained by Continuous Subcutaneous Administration of ND-0612, a Novel Formulation of Levodopa/Carbidopa | May 12, 2022 | EXHIBIT | PETITIONER |
Oren, Continuous Subcutaneous Administration of Levodopa/Carbidopa (ND0612) for the Treatment of Parkinsons Disease | May 12, 2022 | EXHIBIT | PETITIONER |
Haddad et al., Dopamine and Levodopa Prodrugs for the Treatment of Parkinsons Disease | May 12, 2022 | EXHIBIT | PETITIONER |
Stella, Prodrugs Some Thoughts and Current Issues | May 12, 2022 | EXHIBIT | PETITIONER |
United States Patent Application Publication No. 2014/0088192 | May 12, 2022 | EXHIBIT | PETITIONER |
Riley et al., Parkinsons Disease A Giving Smarter Guide | May 12, 2022 | EXHIBIT | PETITIONER |
LeWitt, Levodopa for the Treatment of Parkinsons Disease | May 12, 2022 | EXHIBIT | PETITIONER |
LeWitt, Parkinsons Disease Guide for the Newly Diagnosed | May 12, 2022 | EXHIBIT | PETITIONER |
LeWitt et al., Levodopa therapy for Parkinsons disease A look backward and forward | May 12, 2022 | EXHIBIT | PETITIONER |
FDA Approved Labeling Text for NDA 017555 (Jan. 31, 2011) | May 12, 2022 | EXHIBIT | PETITIONER |
Hauser, Levodopa Past, Present, and Future | May 12, 2022 | EXHIBIT | PETITIONER |
LeWitt et al., Pharmacokinetic-Pharmacodynamic Crossover Comparison of Two Levodopa Extension Strategies | May 12, 2022 | EXHIBIT | PETITIONER |
Guided Poster Tour, Movement Disorders | May 12, 2022 | EXHIBIT | PETITIONER |
Bodor et al., Improved Delivery through Biological Membranes 4. Prodrugs of L-Dopa | May 12, 2022 | EXHIBIT | PETITIONER |
Stella, Prodrugs My Initial Exploration and Where It Led | May 12, 2022 | EXHIBIT | PETITIONER |
Djaldetti et al., Levodopa Ethylester A Novel Rescue Therapy for Response Fluctuations in Parkinsons Disease | May 12, 2022 | EXHIBIT | PETITIONER |
Kleedorfer et al., Subcutaneous and sublingual levodopa methyl ester in Parkinsons disease | May 12, 2022 | EXHIBIT | PETITIONER |
Declaration of Peter A. LeWitt, M.D. | May 12, 2022 | EXHIBIT | PETITIONER |
Declaration of Kenneth B. Sloan | May 12, 2022 | EXHIBIT | PETITIONER |
Petition for Post Grant Review | May 12, 2022 | PAPER | PETITIONER |